Clinical Trial Update: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 platform study evaluating novel immunotherapy combinations in previously untreated, advanced/metastatic non-small cell lung cancer; currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 2 | Status: ACTIVE_NOT_RECRUITING